Single-use systems have greatly improved and simplified common manufacturing issues.
James M. Robinson
Advertisement
James M. Robinson is vice-president of technical and quality operations at Novavax, Inc.
Articles by James M. Robinson
With virus-based production, vaccines can be available in 10-12 weeks.
Advertisement
Latest Updated Articles
Tanks for the MemoriesMarch 1st 2009
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
What 3 Principles Guide Merck's Biologics and ADC Capacity Placement?
4
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
5